SHPH News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

SH

Mkt Cap

$26.5M

Volume

12.19K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

E.F. Hutton & Co. Serves as Exclusive M&A Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin MinerE.F. Hutton & Co. announced it served as exclusive M&A advisor and placement agent for Shuttle Pharmaceuticals Holdings' acquisition of United Dogecoin Inc., creating one of the largest publicly traded Dogecoin mining platforms. The transaction included a $9.6 million PIPE financing to support mining operations expansion with next-generation equipment.Benzinga · May 7, 2026

Shuttle Executes LOI with Molecule.aiShuttle Pharmaceuticals has signed a non-binding letter of intent to acquire Molecule.ai, an AI-driven drug discovery platform, for $10 million. The acquisition aims to leverage advanced machine learning models to accelerate pharmaceutical research and development.Benzinga · Oct 10, 2025

Shuttle Pharma Announces Closing of $5.75 Million Underwritten OfferingShuttle Pharmaceuticals Holdings, Inc. (SHPH) announced the closing of a $5.75 million underwritten public offering. The company plans to use the proceeds to fund its Phase II clinical trial, marketing, and general corporate purposes.Benzinga · Mar 13, 2025

Shuttle Pharma Provides Third Quarter 2024 Corporate UpdateShuttle Pharmaceuticals has successfully dosed the first three patients in its Phase 2 clinical trial of Ropidoxuridine for the treatment of glioblastoma, a deadly brain cancer. The company has also finalized agreements with six clinical trial sites and raised additional funding to support the trial.GlobeNewswire Inc. · Nov 13, 2024

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesShuttle Pharmaceuticals Holdings, Inc. announced the pricing of a $4.5 million public offering, with the proceeds to be used for clinical trials and general corporate purposes.Benzinga · Oct 30, 2024

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesShuttle Pharmaceuticals Holdings, Inc. announced the pricing of a $4.5 million public offering, with the proceeds to be used for clinical trials and general corporate purposes.GlobeNewswire Inc. · Oct 30, 2024

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaShuttle Pharmaceuticals announced the expansion of its Phase 2 clinical trial for Ropidoxuridine, a radiation sensitizer for treating glioblastoma, with four additional trial sites now prepared to enroll patients.GlobeNewswire Inc. · Sep 16, 2024

Shuttle Pharma reports progress in breast cancer treatment By Investing.com - Investing.com CanadaShuttle Pharmaceuticals Holdings, Inc. (SHPH) has announced promising results from a study on a new compound, SP-1-303, which shows potential in inhibiting the growth of estrogen receptor positive breast cancer cells. The compound has been found to activate the ATM protein and modulate estrogen receptor expression, with the ability to sensitize cancer cells to radiation therapy and protect normal tissues.Investing.com · Jul 20, 2024

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE - GlobeNewswireShuttle Pharma's selective HDAC inhibitor, SP-1-303, has shown promising results in inhibiting the growth of estrogen receptor positive breast cancer cells by activating ATM and modulating ER expression.GlobeNewswire Inc. · Jul 19, 2024

Shuttle Pharma Appoints Timothy Lorber as Chief Financial OfficerCurrent CFO, Michael Vander Hoek, transitions to full-time Vice President, Regulatory Current CFO, Michael Vander Hoek, transitions to full-time Vice President, RegulatoryGlobeNewswire Inc. · Jun 18, 2024

SH

SHPHShuttle Pharmaceuticals Holdings, Inc. Common Stock

SHPH

Pay with—

Available Balance0.00

Your PositionYou don't own any SHPH yet.

Related Tickers

Earnings